Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT02972580

Characterization of Clinical Skeletal and Cardiac Impairment in Carriers of DMD and BMD

Characterization of Clinical Skeletal and Cardiac Impairment in Carriers of Duchenne Muscular Dystrophy (DMD) and Becker Muscular Dystrophy (BMD)

Status
Active Not Recruiting
Phase
Study type
Observational
Enrollment
250 (estimated)
Sponsor
Nationwide Children's Hospital · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Accepted

Summary

Longitudinal prospective observational study. This is a 24-month study with the possibility of extending the data time points. Initially baseline, then 12 and 24 months follow up studies will be completed.

Detailed description

Four cohorts are enrolled in this study. The target population is the cohort of genetically confirmed DMD/BMD female carriers (Cohort A). This cohort will consist of 150 DMD/BMD mothers who are somatic carriers of a mutation in the DMD gene. The data collected for this cohort will be compared to three control groups; Control Group B is a cohort of 50 DMD/BMD mothers who are NOT somatic carriers, Control Group C is a cohort of 50 age-matched healthy controls and Control Group D is a cohort of 25 genetically confirmed carriers who do not have an affected child. The inclusion of a Control Group B allows for a comparison to a group of mothers that share the emotional and cognitive burden of caring for an affected male without having the physical or cognitive risks of being a female carrier. The Control Group C offers robust data from an age-matched healthy cohort for purposes of comparison. Control Group D allows for comparison to a group of women that have the same physical or cognitive risks as the Cohort A female carriers, but do not have the same burden of care giving.

Conditions

Interventions

TypeNameDescription
GENETICGenetic characterizationConfirmatory genetic testing for mutation in DMD gene (Carrier Status) for subjects in respective Cohorts

Timeline

Start date
2016-06-01
Primary completion
2030-12-01
Completion
2030-12-01
First posted
2016-11-23
Last updated
2024-08-27

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02972580. Inclusion in this directory is not an endorsement.